JNJ-89495120

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-89495120, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder [Phase 2]